Eli Lilly (LLY) stock is in focus as the company posts late-stage trial win for Retevmo (selpercatinib) lung cancer therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results